文献速递核素与放射性配体治疗放射性药物与辐射防护

用于放射性药物治疗小尺度临床前肾脏剂量学的多肾单位计算模型

A Computational Multinephron Model for Small-Scale Preclinical Renal Dosimetry in Radiopharmaceutical Therapy.
PubMed 文献 · J Nucl Med · 2026-01-02

本研究基于三维多光子显微镜数据构建多肾单位计算模型,包含不同肾单位类型及其主要亚结构,用蒙特卡洛计算多种β-和α发射核素的肾单位级S值,并应用于225Ac非均匀肾组织摄取数据。结果显示亚结构活度分布非均匀导致明显吸收剂量异质性,近髓质亚结构S值最大,为肾毒性关键亚结构识别和肾保护策略提供依据。

要点

  • 多肾单位框架可实现肾单位级剂量学,量化肾组织内吸收剂量异质性。
  • 近髓质亚结构S值最大,α发射体对近端小管自剂量为浅表近端小管S值的7.6-15倍。
  • 案例中不同近端小管吸收剂量比相应肾小球高40%-73%。

核心结论

  • 所开发的多肾单位框架可实现肾单位级剂量学,量化肾组织内吸收剂量异质性。
  • 该框架有助于确定放射性药物治疗中肾毒性的关键肾单位亚结构,支持新型放射性药物临床转化中的肾保护策略。

研究设计与样本

  • 基于三维多光子显微镜数据构建多肾单位计算模型,包括浅表、中皮质和近髓质肾单位类型及其主要亚结构(肾小球、近端小管、远端小管)。
  • 使用蒙特卡洛计算确定多种β-和α发射核素的肾单位级S值。
  • 将多肾单位剂量学框架应用于225Ac非均匀肾组织摄取数据,该摄取主要位于中皮质和近髓质近端小管。

主要发现

  • 非均匀亚结构活度分布导致明显的吸收剂量异质性。
  • S值在不同肾单位类型间差异显著,近髓质亚结构最大。
  • 对考虑的α发射体,近端小管自剂量为浅表近端小管S值的7.6-15倍。
  • 近髓质肾小球交叉剂量平均比浅表肾小球高20%。
  • 案例研究显示明显吸收剂量异质性,不同近端小管吸收剂量比相应肾小球高40%-73%,且游离213Bi对总吸收剂量的贡献与225Ac不同。

临床怎么用

  • 可将多肾单位框架用于临床前放射性药物肾脏剂量学评估,识别肾毒性关键亚结构。
  • 在新型放射性药物临床转化中,可基于肾单位级剂量异质性制定肾保护策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonuniform radiopharmaceutical uptake in kidney tissues leads to substructure-level absorbed dose heterogeneity, confounding the establishment of absorbed dose-effect relationships for nephrotoxicity in radiopharmaceutical therapy. We developed a model to enable nephron-level dosimetry. Methods: A multinephron computational model was developed on the basis of 3-dimensional multiphoton microscopy data, including different nephron types (superficial, midcortical, and juxtamedullary) and their main substructures (glomerulus, proximal tubule [PT], and distal tubule) in kidney tissues. Nephron-level S values were determined using Monte Carlo calculations for several β-- and α-emitting radionuclides. The multinephron dosimetry framework was applied to nonuniform kidney tissue uptake data on 225Ac, located primarily in midcortical and juxtamedullary PTs. Results: A nonuniform substructure activity distribution resulted in pronounced absorbed dose heterogeneities. S values varied substantially among nephron types, with the largest in juxtamedullary substructures. The self-dose to PTs was 7.6-15 times higher than the S value of superficial PTs for the α-emitters considered. The cross dose to juxtamedullary glomeruli was on average 20% higher than to superficial glomeruli. The case study revealed substantial absorbed dose heterogeneity, with the absorbed dose to the different PTs being 40%-73% higher than to their respective glomeruli. Additionally, the contribution of free 213Bi to the total absorbed dose differed from that of 225Ac. Conclusion: The developed multinephron framework enables nephron-level dosimetry, allowing quantification of absorbed dose heterogeneity within renal tissues. Such insights enable establishing critical nephron substructures for nephrotoxicity in radiopharmaceutical therapy, supporting nephroprotective strategies during clinical translation of novel radiopharmaceuticals.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Andersson M, Goudin N, Pontoglio M, et al. A Computational Multinephron Model for Small-Scale Preclinical Renal Dosimetry in Radiopharmaceutical Therapy. J Nucl Med. 2026. PMID: 41167726. doi:10.2967/jnumed.125.270151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。